Prdx2 — Peroxiredoxin 2 is a critical antioxidant enzyme in the neurobiology of neurodegenerative diseases. This page provides comprehensive information about its structure, function, and role in disease processes including Parkinson's disease, Alzheimer's disease, and amyotrophic lateral sclerosis.
| PRDX2 — Peroxiredoxin 2 | |
|---|---|
| Symbol | PRDX2 |
| Full Name | Peroxiredoxin 2 |
| Chromosome | 19p13.13 |
| NCBI Gene | 7003 |
| Ensembl | ENSG00000167612 |
| OMIM | 607386 |
| UniProt | P32189 |
| Diseases | Parkinson's Disease, Alzheimer's Disease, ALS, Stroke |
| Expression | Erythrocytes, Brain, Liver, Kidney, Heart |
PRDX2 (Peroxiredoxin 2) is a gene located on chromosome 19p13.13 that encodes a member of the peroxiredoxin family of antioxidant proteins. PRDX2 is a typical 2-Cys peroxiredoxin that reduces hydrogen peroxide (H₂O₂), peroxynitrite (ONOO⁻), and organic hydroperoxides, playing crucial roles in cellular antioxidant defense and redox signaling. [1]
The peroxiredoxin family comprises six isoforms in mammals (PRDX1-6), with PRDX2 being one of the most abundant cytosolic antioxidants. It is particularly highly expressed in erythrocytes and various tissues including brain, liver, kidney, and heart. [2] PRDX2 functions as both a peroxidase and a molecular chaperone, making it uniquely positioned to protect cells against oxidative damage. [3]
PRDX2 is a 22-kDa protein composed of 198 amino acids. Its structure consists of:
The protein exists primarily as a homodimer, with each monomer containing two conserved cysteine residues essential for catalytic activity. The active site contains a "peroxiredoxin signature" motif (FTFVCPTEI) that defines the 2-Cys peroxiredoxin family. [4]
The enzymatic cycle of PRDX2 involves:
This catalytic mechanism allows PRDX2 to detoxify H₂O₂ at rates approaching diffusion-limited reactions, making it one of the most efficient antioxidant enzymes in the cell. [5]
Under oxidative stress conditions, PRDX2 undergoes a structural transition from a dimeric peroxidase to a high-molecular-weight decameric complex. This oligomerization is induced by:
The decameric form exhibits chaperone activity, protecting proteins from oxidative aggregation. This dual functionality—peroxidase and chaperone—makes PRDX2 particularly important in neurodegenerative conditions where protein aggregation is a hallmark. [6]
PRDX2 is a central component of the cellular antioxidant defense system:
In neurons, PRDX2 provides critical protection against oxidative damage from multiple sources including mitochondrial electron transport leak, inflammatory responses, and environmental toxins. [7]
When oxidized beyond its peroxidase capacity, PRDX2 transitions to a chaperone form that:
This chaperone function is particularly important in neurons, which are post-mitotic and cannot dilute damaged proteins through cell division. [8]
PRDX2 interacts with multiple cell death pathways:
The balance between PRDX2's peroxidase and pro-apoptotic functions is regulated by its oxidation state and oligomeric status. [9]
PRDX2 shows widespread expression:
In the brain, PRDX2 is expressed in both neurons and glia, with particular enrichment in dopaminergic neurons of the substantia nigra—neurons that degenerate in Parkinson's disease. [10]
The cytosolic pool provides general antioxidant protection, while the mitochondrial fraction specifically protects against oxidative damage from electron transport chain leakage. [11]
PRDX2 is oxidized and functionally inactivated in Parkinson's disease brain. Studies show:
The oxidation of PRDX2 in PD may be both a consequence of increased oxidative stress and a contributor to disease progression through loss of antioxidant and chaperone functions. [12]
Key mechanisms in PD:
In Alzheimer's disease, PRDX2 shows altered expression and oxidation:
PRDX2 may protect against amyloid-beta-induced oxidative damage, and its downregulation in AD may contribute to the oxidative stress that drives disease progression. [13]
PRDX2 oxidation has been reported in ALS models and patients:
The selective vulnerability of motor neurons in ALS may be related to their relatively low PRDX2 levels compared to other neuronal populations. [14]
PRDX2 provides neuroprotection against ischemic injury:
In models of focal cerebral ischemia, PRDX2 overexpression reduces infarct size and improves functional outcomes. Studies have shown that PRDX2 administration either as protein therapy or through gene delivery can significantly reduce brain damage following stroke. [15]
PRDX2 alterations have been observed in MSA:
PRDX2 is implicated in PSP pathophysiology:
In FTD, PRDX2 shows:
Ferroptosis is a recently characterized form of regulated cell death that is distinct from apoptosis and necrosis. It is driven by iron-dependent lipid peroxidation, and PRDX2 plays a critical role in regulating this process in neurons[16].
Mechanisms of PRDX2 protection against ferroptosis:
Relevance to neurodegeneration:
The intersection of iron metabolism and redox homeostasis makes PRDX2 particularly important:
PRDX2 is not only important in neurons but also regulates inflammatory responses in glial cells[17]:
Microglial Function:
Astrocyte Support:
PRDX2 affects multiple inflammatory pathways:
PRDX2 function is highly regulated by post-translational modifications that sense the cellular redox state[18]:
Sulfenylation (SOH):
Sulfination (SO₂H) and Sulfonation (SO₃H):
S-Nitrosylation:
PRDX2 activity is modulated by phosphorylation:
PRDX2 interacts with numerous proteins that modulate its function:
| Interactor | Interaction Type | Functional Consequence |
|---|---|---|
| Thioredoxin (Trx) | Substrate provider | Reduces PRDX2 disulfide for regeneration |
| Thioredoxin Reductase (TrxR) | Indirect | Maintains Trx in reduced state |
| ASK1 | Binding partner | Releases upon oxidation to activate JNK pathway |
| JNK | Downstream kinase | Pro-apoptotic signaling when activated |
| p38 MAPK | Interaction | Stress-responsive signaling |
| Vimentin | Binding | Cytoskeletal protection |
| Alpha-synuclein | Colocalization | May seed or inhibit aggregation |
| Amyloid-beta | Interaction | Protection against oxidative damage |
| SOD1 | Co-expression | Synergistic antioxidant defense |
PRDX2 integrates with several critical cellular signaling pathways:
MAPK/ERK Pathway:
PI3K/Akt Pathway:
NF-κB Pathway:
1. PRDX2 Overexpression
2. Enhancement of PRDX2 Activity
3. Stabilization of PRDX2 Oligomers
4. Antioxidant Combination Therapies
PRDX2 has potential as a biomarker for oxidative stress in neurodegeneration:
PRDX2 Knockout Mice:
PRDX2 Transgenic Mice:
PRDX2 modulation affects outcomes in:
| Feature | Normal Neuron | Neurodegeneration |
|---|---|---|
| PRDX2 oxidation | Low | High |
| Oligomerization | Transient | Sustained |
| Chaperone activity | inducible | overwhelmed |
| Thioredoxin system | functional | compromised |
| Cell survival | maintained | impaired |
PRDX2 measurement offers valuable insights into neurodegenerative disease diagnostics:
Cerebrospinal Fluid (CSF) Analysis:
Blood-Based Biomarkers:
Imaging Correlations:
PRDX2 as a therapeutic target requires monitoring:
Target Engagement:
Clinical Endpoints:
PRDX2 is highly conserved across species:
| Species | Sequence Identity | Functional Conservation |
|---|---|---|
| Human | 100% | Complete |
| Mouse | 98% | Full function |
| Zebrafish | 85% | High conservation |
| Drosophila | 72% | Partial function |
| C. elegans | 65% | Peroxidase activity |
Rodent Models:
Lower Organisms:
The study of Prdx2 — Peroxiredoxin 2 has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions. The dual functionality of PRDX2 as both peroxidase and molecular chaperone makes it uniquely positioned to protect neurons from the combined challenges of oxidative stress and protein aggregation that characterize neurodegenerative diseases.
Lee et al. Peroxiredoxin function in oxidative stress response and signaling. Antioxidants & Redox Signaling. 2011. ↩︎
Kim et al. Peroxiredoxin family in cellular antioxidant defense. Free Radical Biology & Medicine. 2008. ↩︎
Riso et al. Oxidative stress triggers peroxiredoxin oligomerization. Journal of Biological Chemistry. 2009. ↩︎
Wang et al. Crystal structure of human peroxiredoxin 2. Nature. 2014. ↩︎
Yang et al. Catalytic mechanism of 2-Cys peroxiredoxins. Free Radical Biology & Medicine. 2009. ↩︎
Hu et al. Peroxiredoxin 2 oligomerization and chaperone function. Cell. 2009. ↩︎
Mann et al. Peroxiredoxin 2 in neuronal antioxidant defense. Journal of Neuroscience. 2006. ↩︎
Fujii et al. Peroxiredoxin as molecular chaperone under oxidative stress. Nature Structural & Molecular Biology. 2010. ↩︎
Yang et al. Regulation of apoptosis by peroxiredoxin 2. Cell Death & Differentiation. 2007. ↩︎
Eng et al. Peroxiredoxin 2 protects dopaminergic neurons from oxidative stress. Neurobiology of Disease. 2015. ↩︎
Ng et al. Mitochondrial peroxiredoxin 2 function. Antioxidants & Redox Signaling. 2016. ↩︎
Perez et al. Peroxiredoxin 2 oxidation in Parkinson's disease substantia nigra. Acta Neuropathologica. 2018. ↩︎
Kim et al. Peroxiredoxin 2 in Alzheimer's disease pathogenesis. Journal of Alzheimer's Disease. 2019. ↩︎
Yang et al. Peroxiredoxin 2 in amyotrophic lateral sclerosis. Brain. 2020. ↩︎
Chen et al. Peroxiredoxin 2 neuroprotection in cerebral ischemia. Stroke. 2019. ↩︎
Nagai et al. Peroxiredoxin 2 regulates ferroptosis in dopaminergic neurons. Cell Death & Disease. 2019. ↩︎
Kar et al. Peroxiredoxin 2 and neuroinflammation in Parkinson's disease. Glia. 2018. ↩︎
Thomson et al. Regulation of peroxiredoxin by reversible oxidation. Antioxidants & Redox Signaling. 2015. ↩︎